News List

UE LifeSciences inks distribution pact with GE Healthcare


UE LifeSciences Inc has announced a distribution partnership with GE Healthcare to commercialize its iBreastExam (iBE) in countries across South Asia and Africa.

By Team ABLE

USA-India based med-tech startup UE LifeSciences Inc has announced a distribution partnership with GE Healthcare to commercialize its iBreastExam (iBE) in countries across South Asia and Africa.

The partnership brings together UE LifeSciences\' skills to design and develop mobile health innovations, and GE Healthcare\'s sales, marketing and distribution expertise in these markets to enable early detection of breast cancer in the developing world, the company officials said.

UE LifeSciences, Founder and CEO, Mihir Shah had expressed that the iBreastExam can create access where none exists right now across its partnership geography.
This partnership will provide a significant opportunity to commercially scale-up iBE across India, South Asia, Africa and South-East Asia and also work towards improving breast cancer related outcomes in these regions, said GE Healthcare Sustainable Healthcare Solutions President and CEO, Terri Bresenham.
iBE is a Made in India device developed by a team of 20-plus scientists, engineers and clinicians with USD 1.3 million in grant funding from Pennsylvania Department of  Health (CURE Grant), University City Science Center (QED &  DHA), Drexel University (Coulter Programme) and Unitus Seed Fund (StartHealth grant). It is currently commercially available in India, Myanmar and Botswana.

The project has been mentored and invested by Dr Kiran Mazumdar-Shaw of Biocon, Dr Ranjan Pai of Manipal Education and Medical Group and Unitus Seed Fund, a social impact investor in affordable healthcare innovations.